Abstract P6-10-19: Bone mineral density(BMD) monitoring in postmenopausal women with early stage estrogen and/or progesterone receptor positive breast cancer on aromastase inhibitor(AI) therapy at University of Toledo medical center. A quality improvement project Meeting Abstract (Web of Science)

authors

publication date

  • 2015

webpage